MHH Logo




Naumann M, Toyka KV, Mansouri Taleghani B, Ahmadpour J, Reiners K, Bigalke H.

Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin.

J Neurol Neurosurg Psychiatry. 1998 Dec;65(6):924-7.



Barth H, Preiss JC, Hofmann F, Aktories K.

Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botulinum C2 toxin by site-directed mutagenesis.

J Biol Chem. 1998 Nov 6;273(45):29506-11.



Gerhard R, Schmidt G, Hofmann F, Aktories K.

Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells.

Infect Immun. 1998 Nov;66(11):5125-31.



Paul Y, Weiss A, Adermann K, Erdmann G, Kassebaum C, Lazarovici P, Hochman J, Wellhoner H.

Translocation of acylated pardaxin into cells.

FEBS Lett. 1998 Nov 27;440(1-2):131-4.



Adermann K, Raida M, Paul Y, Abu-Raya S, Bloch-Shilderman E, Lazarovici P, Hochman J, Wellhoner H.

Isolation, characterization and synthesis of a novel paradaxin isoform.

FEBS Lett. 1998 Sep 18;435(2-3):173-7.



Busch C, Hofmann F, Selzer J, Munro S, Jeckel D, Aktories K.

A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins.

J Biol Chem. 1998 Jul 31;273(31):19566-72.



Herrmann C, Ahmadian MR, Hofmann F, Just I.

Functional consequences of monoglucosylation of Ha-Ras at effector domain amino acid threonine 35.

J Biol Chem. 1998 Jun 26;273(26):16134-9.



Schmid G, Schürmann A, Huppertz C, Hofmann F, Aktories K, Joost HG.

Inhibition of insulin-stimulated glucose transport in 3T3-L1 cells by Clostridium difficile toxin B, Clostridium sordellii lethal toxin, and Clostridium botulinum C2 toxin.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):385-92.



Ben-Ami G, Ozeri V, Hanski E, Hofmann F, Aktories K, Hahn KM, Bokoch GM, Rosenshine I.

Agents that inhibit Rho, Rac, and Cdc42 do not block formation of actin pedestals in HeLa cells infected with enteropathogenic Escherichia coli.

Infect Immun. 1998 Apr;66(4):1755-8.



Barth H, Hofmann F, Olenik C, Just I, Aktories K.

The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.

Infect Immun. 1998 Apr;66(4):1364-9.



Hofmann F, Busch C, Aktories K.

Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition.

Infect Immun. 1998 Mar;66(3):1076-81.



Reiser CO, Lanz T, Hofmann F, Hofer G, Rupprecht HD, Goppelt-Struebe M.

Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins.

Biochem J. 1998 Mar 15;330 ( Pt 3):1107-14.



Lucius C, Arner A, Steusloff A, Troschka M, Hofmann F, Aktories K, Pfitzer G.

Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins.

J Physiol. 1998 Jan 1;506 ( Pt 1):83-93.



Sehr P, Joseph G, Genth H, Just I, Pick E, Aktories K.

Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.

Biochemistry. 1998 Apr 14;37(15):5296-304.



Wohlfarth K, Goeschel H, Frevert J, Dengler R, Bigalke H.

Dose standardisation of botulinum toxin: Reply.

Mov Disord. 1998, 13, 750-751.



Boquet P, Munro P, Fiorentini C, Just I.

Toxins from anaerobic bacteria: speficity and molecular mechanism of action.

Curr Opinion Microbiol 1998;1;66-74